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Abstract
Background: Although synovial cell sarcoma is a common tumor of the extremities, its
occurrence in the thorax has been less frequently documented.
Case presentation: A 46-year-old Pakistani man presented with a 2 month history of
progressively increasing cough and left lower chest pain. Initial evaluation was done using a chest
x-ray; the patient was found to have a large mass involving the lower portion of the left chest. A
computed tomography scan was performed next which showed a large mass involving the left chest
wall with invasion into the pericardium and left hemidiaphragm. En bloc surgical resection of the
tumor was undertaken. Final pathology showed synovial cell sarcoma of the thorax. At one-year
follow-up, the patient has shown no recurrence of the disease.
Conclusion: We have described a rare case of a large synovial cell sarcoma of the thorax. Surgical
resection appears an appropriate modus operandi for managing giant synovial cell sarcomas of the
thorax. However, there is a need to clearly define post-operative strategies for cases with
extensive involvement of surrounding structures.
Background
Synovial cell sarcoma (SCS) is a common tumor of the
extremities. However, SCS of the thorax is an overall rare
clinical entity. We report here a case of SCS in a 46-year-
old man with extensive involvement of the chest wall,
lung and diaphragm.
Case presentation
A 46-year-old Pakistani man presented to our hospital
with a 2 months history of progressively increasing cough
and left lower chest pain. Initial evaluation was done
using a chest x-ray and he was found to have a large mass
involving the lower portion of the left chest. Computed
tomography (CT) scan was obtained next to better delin-
eate the disease process (Figure 1). It showed a 16 × 15 cm
mass involving the left chest wall and left lower lobe of
the lung with invasion into the pericardium and left
hemidiaphragm. There was no pericardial or pleural effu-
sion. CT scan of the abdomen-pelvis was normal.
Trucut biopsy of this mass showed features of SCS. In the
absence of effective chemotherapy and obvious metasta-
sis, the patient was planned for a complete resection of
this tumor. The tumor was exposed via a left posterola-
teral thoracotomy approach. Intra-operatively, a large
tumor with extensive involvement of the left lower chest
wall from the 4th to 10th ribs was seen. It was also involv-
ing the left lower lung lobe, left hemidiaphragm and peri-
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cardium (Figure 2). The mass was removed en bloc with
all involved ribs, left lower lung lobe, left hemidiaphragm
and pericardium. Final pathology confirmed it to be SCS
sarcoma with negative histological margins. The post
operative course of the patient was unremarkable. He was
discharged on the 9th postoperative day. At follow-up
after one year, the patient has shown no recurrence of the
disease.
Discussion
SCS is a malignant tumor that has been termed such
because of histological resemblance to developing syn-
ovium [1]. It is thought to arise from primitive pluripotent
mesenchymal cells rather than the synovium [2]. SCS is
the third most common sarcoma of the extremities after
liposarcoma and malignant fibrous histiocytoma [3] and
has been found to account for 5 - 14% of soft tissue sarco-
mas in different studies [1,4,5]. Apart from the extremi-
ties, SCS may also occur in the pericardium, pleura, lung,
sternum, esophagus, retroperitoneum, mediastinum,
mesentery, head and neck, abdominal and thoracic wall,
prostate and kidney; albeit with lesser frequency.
SCS of the thorax represents a diagnostic challenge
because of the diverse array of competing diagnosis and
rarity of incidence [6]. The symptoms of a patient with
SCS of the thorax depend on the structures undergoing
compression or invasion from the tumor. Patients may
present with chest pain, coughing, hemoptysis, dyspnea,
reduced breath sounds and weight loss. Primary thoracic
SCS sarcomas typically occur as chest wall masses that
exhibit a propensity for invasion into surrounding struc-
tures. Immunohistochemically, synovial sarcomas show
immunoreactivity for cytokeratins, EMA, S-100 protein,
are positive for Bcl-2, O-13, Actin and negative for CD34
and Desmin [7]. Young age, Her-2 expression, complete
resection with clear surgical margins and response to first
line chemotherapy were found as good prognostic indica-
tors in advanced disease in different studies [1,8,9].
Adverse prognostic factors for SCS include lesions larger
than 5 cm, male gender, extensive tumor necrosis, neurov-
ascular invasion, aneuploidy and poor histological differ-
entiation [4,10,11]. Definitive diagnosis of SCS can be
made with biopsy and use of immunohistochemistry,
electron microscopy and cytogenetic analysis [6,12]. CT
scan and magnetic resonance imaging (MRI) are imaging
modalities employed for the evaluation of respectability
and staging of the neoplasm.
Treatment of choice for SCS sarcomas of the thorax is exci-
sion, radiation therapy and adjuvant chemotherapy fol-
lowing resection. In our case, successful surgical resection
was performed for a large synovial sarcoma of the left
chest wall with involvement of left lung, pericardium and
left hemidiaphragm. The diaphragm and left chest wall
had to be reconstructed with prolene mesh and muscle
flap after complete resection of tumor. Our patient is not
receiving any radiation therapy because of proximity of
the bare heart to the chest wall. Also, the need for adjuvant
therapy was obviated because of achievement of histolog-
ically negative margins. As SCS is known to recur, the
patient needs to be followed up carefully.
Conclusion
We have documented a rare case of a giant SCS of the tho-
rax with extensive involvement of surrounding structures.
This is a rare clinical entity and there is a need to clearly
Computed tomography scan of the chest showing a large synovial cell sarcoma with extensive involvement of sur-rounding structuresFigure 1
Computed tomography scan of the chest showing a 
large synovial cell sarcoma with extensive involve-
ment of surrounding structures.
Large synovial cell sarcoma with extensive involvement of the chest wall, pericardium, left hemidiaphragm and lef  lower lu g lobeFigu  2
Large synovial cell sarcoma with extensive involve-
ment of the chest wall, pericardium, left hemidia-
phragm and left lower lung lobe.
Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Cases Journal 2009, 2:9324 http://www.casesjournal.com/content/2/1/9324
Page 3 of 3
(page number not for citation purposes)
define post-operative strategies for a case with extensive
involvement like ours.
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